Toripalimab Combined With CAV / IE Regimen

• Status: Recruiting
• Trial end date: 2022-12-30

Summary

The aim of this study was to investigate the efficacy and safety of CAV / IE chemotherapy combined with toripalimab in the treatment of patients with advanced or unresectable bone and soft tissue sarcomas who failed in standard treatment.

• Phase: Phase 2

Details

• Lead Sponsor: Sun Yat-sen University